In the first incident, a 52-year-old man was allegedly contacted by fraudsters through Telegram app and ended up losing ₹53 ...
Hosted on MSN11m
Broker Upgrades: Canaccord says disease specialist Opthea could triple if Phase III trial passes musterCanaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as ... Read More The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback